Medicine and Dentistry
Adverse Event
11%
Bisphosphonate
25%
Bone Density
33%
Bone Fragility
6%
CADASIL Syndrome
25%
CHRNA4
25%
Closed Head Injury
25%
Diagnosis
11%
Distal Femur
6%
Early Diagnosis
25%
Echography
5%
Epileptic Seizure
29%
Gestational Age
7%
Hospital Mortality
8%
Intensive Care
25%
Lumbar Spine
10%
Meta-Analysis
8%
Placebo
6%
Randomized Controlled Trial
25%
Retrospective Study
25%
Secondary Osteoporosis
25%
Spastic Diplegia
100%
Symptom
5%
Zoledronic Acid
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
11%
Bisphosphonic Acid Derivative
25%
Bone Fragility
6%
Cerebral Palsy
75%
Head Injury
25%
Hospital Mortality
12%
Placebo
6%
Randomized Controlled Trial
25%
Retrospective Study
25%
Secondary Osteoporosis
25%
Zoledronic Acid
25%
Neuroscience
Cerebral Palsy
50%
CHRNA4
25%
Dual-Energy X-Ray Absorptiometry
8%
Encephalopathy
25%
Epileptic Absence
9%
Eyelid
6%
Mosaicism
6%
Myoclonus
6%
Nightmare
25%
Placebo
16%
Randomized Controlled Trial
25%
Ultrasonography
5%